Trial
NCT04326439
AflacLL1901 (CHOA-AML)
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Emory University
Collaborators
—
Condition
Acute Myeloid Leukemia
Intervention
Cytarabine
Why stopped
Due to unforeseen circumstances, the study team was limited in enrolling patients on this trial; thus, it was terminated.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-06-15